Located close to Magdeburg, the EKF-diagnostic GmbH is a well established exhibitor at the MEDICA trade fair since many years. Presenting its latest product developments in glucose, lactate and hemoglobin diagnosis on an impressing new booth, the company also showed a range of 3rd party products for the first time.
"Based on our long-term gained, good market position, there are increasing sales opportunities also for complementing product solutions" explains the founder and CEO Berthold Walter. First steps with lab tools, hematology analyzers and SpO2 sensors were realized successfully. This range will now be added by the Microcatheters from the Swedish company CMA/Microdialysis AB, to distribute in German speaking countries and the Gulf region.
These catheters are mainly used in patient monitoring, intensive care and research to detect early chemical markers of Ischemia and cell damages. Meeting international acceptance since 10 years, CMA/Microdialysis offers a unique portfolio of hepatic, gastrointestinal, brain and other kind of established and innovative catheters.
"Synergy effects were noticed at first customer contacts as expect, and confirmed by many MEDICA visitors" adds Berthold Walter. Co-workers of CMA's German sales office are now employed by EKF to ensure the continual market approach and to develop the shareable business. "The combination of lab analyzers, POC diagnostics and clinical monitoring tools is the perfect mix, fitting to current and future demands. 2008 was a very successful year for EKF, expanding our core activities and strategic arrangements as well."
Apart from new production and stock buildings at the headquarter in Barleben/ Magdeburg, the company endeavours the foundation of a holding in 2009 to set up more effective management and administration structures.
"Based on our long-term gained, good market position, there are increasing sales opportunities also for complementing product solutions" explains the founder and CEO Berthold Walter. First steps with lab tools, hematology analyzers and SpO2 sensors were realized successfully. This range will now be added by the Microcatheters from the Swedish company CMA/Microdialysis AB, to distribute in German speaking countries and the Gulf region.
These catheters are mainly used in patient monitoring, intensive care and research to detect early chemical markers of Ischemia and cell damages. Meeting international acceptance since 10 years, CMA/Microdialysis offers a unique portfolio of hepatic, gastrointestinal, brain and other kind of established and innovative catheters.
"Synergy effects were noticed at first customer contacts as expect, and confirmed by many MEDICA visitors" adds Berthold Walter. Co-workers of CMA's German sales office are now employed by EKF to ensure the continual market approach and to develop the shareable business. "The combination of lab analyzers, POC diagnostics and clinical monitoring tools is the perfect mix, fitting to current and future demands. 2008 was a very successful year for EKF, expanding our core activities and strategic arrangements as well."
Apart from new production and stock buildings at the headquarter in Barleben/ Magdeburg, the company endeavours the foundation of a holding in 2009 to set up more effective management and administration structures.
